---
title: "Regulated Pathways - MedTech Ecosystems"
description: "Submission types, review pathways, and the regulators who run them - from 510(k) and PMA to CE marking under MDR and global routes through PMDA, NMPA, and MHRA."
lang: en
json-ld:
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

[All ecosystems](/ecosystems)

Ecosystem 

# Regulated Pathways

Submission types, review pathways, and the regulators who run them - from 510(k) and PMA to CE marking under MDR and global routes through PMDA, NMPA, and MHRA.

114 terms

## Regulatory99 

-   [510(k) Premarket Notification(510(k)) ](/terms/510k)
-   [510(k) Summary vs 510(k) Statement ](/terms/510k-summary-vs-statement)
-   [513(g) Request for Information(513(g)) ](/terms/513g)
-   [Abbreviated 510(k) ](/terms/abbreviated-510k)
-   [Accreditation Scheme for Conformity Assessment(ASCA) ](/terms/asca)
-   [Additional Condition for Nonprescription Use(ACNU) ](/terms/acnu)
-   [AI Act Conformity Assessment (Medical Devices) ](/terms/ai-act-conformity-assessment)
-   [AI Act Post-Market Monitoring ](/terms/ai-act-post-market-monitoring)
-   [AI Act Prohibited Practices ](/terms/ai-act-prohibited-practices)
-   [AI Act Serious Incident Reporting ](/terms/ai-act-serious-incident-reporting)
-   [AI Act Technical Documentation (Annex IV) ](/terms/ai-act-technical-documentation)
-   [AI Act Transparency Obligations ](/terms/ai-act-transparency-obligations)
-   [Analytical Performance (IVDR) ](/terms/ivdr-analytical-performance)
-   [ANVISA(ANVISA) ](/terms/anvisa)
-   [Authorized Representative (EU)(EC REP) ](/terms/ec-rep)
-   [Benefit-Risk Determination ](/terms/benefit-risk)
-   [Breakthrough Device Designation(BDD) ](/terms/breakthrough-device)
-   [CE Mark ](/terms/ce-mark)
-   [Class D Batch Verification (IVDR) ](/terms/ivdr-class-d-batch-verification)
-   [Class III Device ](/terms/class-iii)
-   [Clinical Performance (IVDR) ](/terms/ivdr-clinical-performance)
-   [Combination Product ](/terms/combination-product)
-   [Common Specifications(CS) ](/terms/common-specifications)
-   [Common Specifications (IVDR)(CS) ](/terms/ivdr-common-specifications)
-   [Companion Diagnostic (IVDR)(CDx) ](/terms/ivdr-companion-diagnostic)
-   [De Novo Classification Request(De Novo) ](/terms/de-novo)
-   [Device Master File(MAF) ](/terms/device-master-file)
-   [Device Reclassification Petition ](/terms/reclassification-petition)
-   [Electronic Instructions for Use(eIFU) ](/terms/eifu)
-   [Emergency Use Authorization(EUA) ](/terms/eua)
-   [eSTAR ](/terms/estar)
-   [EU In Vitro Diagnostic Regulation(IVDR) ](/terms/ivdr)
-   [EU Medical Device Regulation(MDR) ](/terms/mdr)
-   [EU Reference Laboratory (EURL)(EURL) ](/terms/ivdr-eu-reference-laboratory)
-   [EUDAMED ](/terms/eudamed)
-   [FDA Recognized Consensus Standards ](/terms/recognized-standards)
-   [Fundamental Rights Impact Assessment(FRIA) ](/terms/ai-act-fria)
-   [General Controls ](/terms/general-controls)
-   [General Safety and Performance Requirements(GSPRs) ](/terms/gspr)
-   [General Safety and Performance Requirements (IVDR)(GSPR) ](/terms/ivdr-gspr)
-   [General-Purpose AI Model(GPAI) ](/terms/ai-act-gpai)
-   [Genetic Testing Requirements (IVDR Article 4) ](/terms/ivdr-genetic-testing)
-   [Health Canada Medical Device Licence(MDL) ](/terms/health-canada-mdl)
-   [High-Risk AI System (EU AI Act) ](/terms/ai-act-high-risk-system)
-   [Humanitarian Device Exemption(HDE) ](/terms/hde)
-   [IMDRF ](/terms/imdrf)
-   [Importer and Distributor Obligations (EU) ](/terms/importer-distributor)
-   [In-House IVDs (Article 5(5)) ](/terms/ivdr-in-house-devices)
-   [Indications for Use(IFU (statement)) ](/terms/indications-for-use)
-   [Instructions for Use(IFU) ](/terms/ifu)
-   [Intended Use ](/terms/intended-use)
-   [ISO 20916 ](/terms/iso-20916)
-   [IVDR Conformity Assessment Routes ](/terms/ivdr-conformity-assessment-routes)
-   [IVDR Legacy Device ](/terms/ivdr-legacy-device)
-   [IVDR Performance Evaluation ](/terms/ivdr-performance-evaluation)
-   [IVDR Risk Classes A–D ](/terms/ivdr-classes)
-   [IVDR Transitional Provisions ](/terms/ivdr-transitional-provisions)
-   [Labeling ](/terms/labeling)
-   [Letter to File(LTF) ](/terms/letter-to-file)
-   [MDR Article 117 ](/terms/mdr-article-117)
-   [Medical Device Coordination Group Guidance(MDCG) ](/terms/mdcg)
-   [Medical Device User Fee Amendments(MDUFA) ](/terms/mdufa)
-   [Metrological Traceability (IVDR) ](/terms/ivdr-metrological-traceability)
-   [MHRA / UKCA Marking(MHRA / UKCA) ](/terms/mhra-ukca)
-   [Ministry of Food and Drug Safety (Korea)(MFDS) ](/terms/mfds)
-   [Modular PMA ](/terms/pma-modular)
-   [National Medical Products Administration(NMPA) ](/terms/nmpa)
-   [NMPA Innovative Medical Device Pathway ](/terms/nmpa-innovation)
-   [Notified Body(NB) ](/terms/notified-body)
-   [Notified Body Scrutiny (IVDR Class D) ](/terms/ivdr-notified-body-scrutiny)
-   [Performance Study Application (IVDR) ](/terms/ivdr-performance-study-application)
-   [Person Responsible for Regulatory Compliance(PRRC) ](/terms/prrc)
-   [Pharmaceuticals and Medical Devices Agency(PMDA) ](/terms/pmda)
-   [PMA Supplement Types ](/terms/pma-supplement-types)
-   [Post-Market Performance Follow-Up (IVDR)(PMPF) ](/terms/ivdr-pmpf)
-   [Post-Market Surveillance Plan (IVDR) ](/terms/ivdr-pms-plan)
-   [Predicate Device ](/terms/predicate-device)
-   [Premarket Approval(PMA) ](/terms/pma)
-   [Provider and Deployer (EU AI Act) ](/terms/ai-act-provider-deployer)
-   [Q-Submission (Pre-Submission)(Q-Sub / Pre-Sub) ](/terms/q-sub)
-   [Real-Time PMA Supplement Review ](/terms/pma-real-time-review)
-   [Refuse to Accept(RTA) ](/terms/rta)
-   [Request for Designation(RFD) ](/terms/rfd)
-   [Safer Technologies Program(STeP) ](/terms/step)
-   [Saudi Food and Drug Authority(SFDA) ](/terms/sfda)
-   [Scientific Validity (IVDR) ](/terms/ivdr-scientific-validity)
-   [Self-Test and Near-Patient Testing (IVDR) ](/terms/ivdr-self-test)
-   [Special 510(k)(Special 510(k)) ](/terms/special-510k)
-   [Special Controls ](/terms/special-controls)
-   [Substantial Equivalence(SE) ](/terms/substantial-equivalence)
-   [Summary of Safety and Clinical Performance(SSCP) ](/terms/sscp)
-   [Summary of Safety and Performance (IVDR)(SSP) ](/terms/ivdr-summary-safety-performance)
-   [Swissmedic ](/terms/swissmedic)
-   [Systemic Risk (GPAI) ](/terms/ai-act-systemic-risk)
-   [Therapeutic Goods Administration(TGA) ](/terms/tga)
-   [Third-Party Review of 510(k)(3P 510(k)) ](/terms/third-party-510k)
-   [UK Responsible Person(UKRP) ](/terms/ukrp)
-   [Unique Device Identification(UDI) ](/terms/udi)
-   [WHO Prequalification (Diagnostics)(WHO PQ Dx) ](/terms/who-pq-dx)

## Cybersecurity1 

-   [Premarket Cybersecurity Submission ](/terms/premarket-cybersecurity)

## Clinical & Trials4 

-   [Clinical Evaluation Plan(CEP) ](/terms/clinical-evaluation-plan)
-   [Clinical Evaluation Report(CER) ](/terms/cer)
-   [Clinical Investigation Plan(CIP) ](/terms/cip)
-   [Performance Study (IVDR) ](/terms/ivdr-performance-study)

## Manufacturing1 

-   [Pre-Approval Inspection(PAI) ](/terms/pai)

## Post-Market8 

-   [5-Day Report ](/terms/five-day-report)
-   [Annual Report (PMA) ](/terms/annual-report-pma)
-   [Medical Device Reporting (FDA)(MDR) ](/terms/mdr-reporting)
-   [Periodic Safety Update Report(PSUR) ](/terms/psur)
-   [Post-Market Clinical Follow-up(PMCF) ](/terms/pmcf)
-   [Post-Market Performance Follow-up(PMPF) ](/terms/pmpf)
-   [PSUR (IVDR Specific) ](/terms/psur-ivdr)
-   [Trend Reporting (MDR/MIR) ](/terms/trend-reporting)

## Reimbursement1 

-   [Transitional Coverage for Emerging Technologies(TCET) ](/terms/tcet)

### Other ecosystems

[AI / ML in Devices](/ecosystems/ai-ml)[Connected & Cyber-Physical Devices](/ecosystems/connected-devices)[Software Lifecycle](/ecosystems/software-lifecycle)[Quality System](/ecosystems/quality-system)[Clinical Evidence](/ecosystems/clinical-evidence)[Post-Market & Safety](/ecosystems/post-market-safety)[Global Markets](/ecosystems/global-markets)[Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)[Startup Lifecycle](/ecosystems/startup-lifecycle)[Strategic Landscape](/ecosystems/strategic-landscape)[Manufacturing & Supply](/ecosystems/manufacturing-supply)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)